Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

A woman's liver problems improved after she stopped taking spironolactone.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.